Eslicarbazepine acetate


( Last Updated : August 15, 2014)
Generic Name:
Eslicarbazepine acetate
Project Status:
Complete
Therapeutic Area:
Epilepsy, partial-onset seizures
Manufacturer:
Sunovion Pharmaceuticals Canada Inc.
Call for patient/clinician input open:
Brand Name:
Aptiom
Project Line:
Reimbursement Review
Project Number:
SR0391-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Epilepsy, partial-onset seizures
Recommendation Type:
List with criteria/condition
Final Recommendation: